Retirement Comes Early For Seniors Hopped Up On Poligrip

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

From 24/7 Wall St. affiliate Heathcare Outsider

The New York Times reports that last month, GlaxoSmithKline (the pharmaceutical company that can do nothing right) recalled a popular dental adhesive called Super Poligrip from the market because it contained high levels of Zinc, and some people who used the cream had shown some adverse symptoms associated with the effects of Zinc poisoning (they were dying.) Zinc – you probably know it as the last ingredient listed on your unopened bottle of Centrum. You may also be familiar with its usage as an anti-corrosive, a component used to galvanize steel, and an adhesive agent in denture creams. What you probably didn’t know is that studies like this one (from the American Journal of Clinical Nutrition) have identified the metal as a toxic agent, and that long-term exposure to it can lead to nerve damage, anemia, and death.

While most of the things that go wrong with GSK are accidents caused by whatever ancient curse was placed upon them, this might not be the case with not-so-Super Poligrip. Apparently, warnings about the potential side effects of Zinc have been available for quite some time (decades). Even more troubling, at least one of these, featured in the journal Neurology, directly cited dental cream as a potential vehicle for poisoning. GSK’s response to this was to insert a tiny pamphlet in Super Poligrip boxes suggesting people apply the cream sparingly. Considering the target audience for dental adhesives (people old enough to need dentures) this seems to be not unlike doing absolutely nothing.

Organizations like the American Dental Association are skeptical about all the to-do surrounding adhesives and Zinc poisoning. They suggest the victims were simply using far too much of the product, and were accidentally swallowing small quantities. At risk of sounding a little paternalistic, it doesn’t seem entirely fair to blame the elderly folks who haven’t done all their reading on the potential side effects of Zinc overexposure. It seems more likely that a company should consider its target audience when marketing a product that can potentially put you in a wheelchair or kill you if you don’t read the fine print.

Regardless, all’s well that ends well. we’re sure GSK will never market something again without exploring all possible side effects, and people with dentures can always use Procter & Gamble’s (PG) Fixodent, which only has half as much Zinc as Super Poligrip did. We’re sure that’s much safer.

Michael B. Sauter

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618